IMMUNOCYTOCHEMICAL STUDY OF GELATINASES AND THEIR TISSUE INHIBITORS IN BRAIN CAPILLARIES IN NORMO- AND HYPERTENSIVE RATS



如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective - to study the distribution of MMP-2 and MMP-9 and their tissue inhibitors (TIMP-2 and TIMP-1) in the capillaries of rat brain in renovascular hypertension (RVHT). Materials and methods. The research was conducted on 35 Wistar rats with RVHT modelled by a surgical method (ligature on the left renal artery and vein). The immunohystochemical study of MMP-2, MMP-9, TIMP-2 and TIMP-1 in brain capillaries was conducted 2, 4, 6, 8, 12, 16 and 20 weeks after surgery (5 animals in each group). Level of an expression of each enzyme was estimated on the basis of concentration of the corresponding immunopositive capillaries. Then a ratio of MMP-2/TIMP-2 and MMP-9/TIMP-1 was calculated in cerebral cortex and white matter. Results. MMP-2 and TIMP-2 were found in the capillaries of the cortex and white matter, both in control animals, and during RVHT development, while MMP-9 and TIMP-1 were detected only in rats with RVHT. The number of MMP-2-positive capillaries considerably increased in the 2nd week, that of MMP-9-positive capillaries - in the 12th week of RVHT development, while the content of TIMP-2 and TIMP-1-positive capillaries was reduced to the minimal level during the specified periods, leading to significant changes of MMPs/TIMPs ratio. Conclusion. The balance between MMPs and TIMPs was disturbed during RVHT development. which is indicated by the changes of MMPs/TIMPs ratio in capillaries of the cortex and white matter. These processes may result in the destructive alterations of the blood-brain barrier, thus increasing the risk of complications in arterial hypertension.

全文:

受限制的访问

作者简介

N. Zakharchuk

Pacific State Medical University

Email: zaharchuknat@mail.ru
Institute of Therapy and Instrumental Diagnostics 2 Prospekt Ostryakova, Vladivostok 690002

V. Chertok

Pacific State Medical University

Email: chertokv@mail.ru
Department of Human Anatomy 2 Prospekt Ostryakova, Vladivostok 690002

V. Nevzorova

Pacific State Medical University

Institute of Therapy and Instrumental Diagnostics 2 Prospekt Ostryakova, Vladivostok 690002

A. Chertok

Pacific State Medical University

Department of Human Anatomy 2 Prospekt Ostryakova, Vladivostok 690002

参考

  1. Потеряева О. Н. Матриксные металлопротеиназы: строение, регуляция, роль в развитии патологических состояний (обзор литературы) // Медицина и образование в Сибири. 2010. № 5. С. 7-17.
  2. Черток В. М. Тучные клетки наружной оболочки артерий основания головного мозга // Морфология. 1980. Т. 79, вып. 11. С. 72-79.
  3. Черток В. М., Захарчук Н. В., Черток А. Г. Клеточно-молекулярные механизмы регуляции ангиогенеза в головном мозге // Журнал неврологии и психиатрии им. C. C. Корсакова. 2017. Т. 117, № 8-2. С. 43-55. doi.org/10.17116/jnevro20171178243-55.
  4. Черток В. М., Черток А. Г. Регуляторный потенциал капилляров мозга // Тихоокеанский медицинский журнал. 2016. Т. 64, № 2. С. 72-80. doi. org/10.17238/ pmj1609-1175.2016.2.72-81.
  5. Черток В. М., Черток А. Г., Захарчук Н. В., Невзорова В. А. Динамика распределения капилляров, содержащих матриксную металлопротеиназу-2 и ее тканевой ингибитор, в головном мозге крыс с экспериментальной гипертензией // Бюл. экспер. биол. и мед. 2017. Т. 164, № 9. С. 385-389.
  6. Candelario-Jalil E., Yang Y., Rosenberg G. A. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia // Neuroscience. 2009. Vol. 158, № 3. P. 983-994. https:// doi. org/10.1016/j.neuroscience.2008.06.025.
  7. Cunningham L. A., Wetzel M., Rosenberg G. A. Multiple roles for MMPs and TIMPs in cerebral ischemia // Glia. 2005. Vol. 50, № 4. P. 329-339. https://doi.org/10.1002/glia.20169.
  8. Falzone L., Salemi R., Travali S., Scalisi A., McCubrey J., Can dido S., Libra M. MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma // Aging. 2016. Vol. 8, № 5. Р. 933-944. https://doi.org/10.18632/ aging.100951.
  9. Florczak-Rzepka M., Grond-Ginsbach C., Montaner J., Steiner T. Matrix metalloproteinases in human spontaneous intracerebral hemorrhage: an update // Cerebrovasc Dis. 2012. Vol. 34, № 4. P. 249-262. https://doi.org/10.1159/000341686.
  10. Grandas O. H., Mountain D. H., Kirkpatrick S. S., Rudrapatna V. S., Cassada D. C., Stevens S. L., Freeman M. B., Goldman M. H. Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure // J. Vasc. Surg. 2009. Vol. 49, № 1. P. 185-191. https://doi.org/10.1016/j. jvs.2008.07.080.
  11. Hiller O., Lichte A., Oberpichler A., Kocourek A., Tschesche H. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII // J. Biol. Chem. 2000. № 275. P. 33 008-33 013.
  12. Johnson C., Galis Z. S. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization // Arterioscler. Thromb. Vasc. Biol. 2004. № 24. P. 54-60. https://doi.org/10.1161/01. atv.0000100402.69997.c3.
  13. Lakhan Sh.E., Kirchgessner A., Tepper D., Leonard A. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke // Front Neurol. 2013. № 4. P. 32-56. https:// doi.org/10.3389/fneur.2013.00032.
  14. Ramachandran R. K., Sorensen M. D., Aaberg-Jessen C., Hermansen S. K., Kristensen B. W. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas // PLoS One. 2017. Vol. 12, № 2. Р. е0172234. https://doi. org/10.1371/journal.pone.0172234.
  15. Rempe R. G., Hartz A. M., Bauer B. Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers // J. Cereb. Blood Flow Metab. 2016. Vol. 36, № 9. P. 1481- 1507. https://doi.org/10.1177/0271678x16655551

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eco-Vector, 2018



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 0110212 от 08.02.1993.
##common.cookie##